# A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

> **NCT04715646** · PHASE3 · RECRUITING · sponsor: **UCB Biopharma SRL** · enrollment: 70 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Brivaracetam

## Key facts

- **NCT ID:** NCT04715646
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-11
- **Primary completion:** 2030-07-08
- **Final completion:** 2030-07-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04715646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04715646, "A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04715646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*